ASX Announcements
Market Sensitive
BTC Infusion Pumps Approved for Reimbursement on PL
Progress Report
- Oct 25, 2024
- 1 page
Notice of Annual General Meeting and Proxy Form
Notice of Annual General Meeting, Proxy Form
- Oct 25, 2024
- 21 pages
August 2021
Telix Pharma is on the cusp of first US FDA approval
The nuclear medicine company is not only going after the huge US market, it has the equivalent documentations with 17 other countries’ regulators.
- Carrie LaFrenz
August 2016
How the rich invest: Lang Walker experiments with biotechnology stocks
Rich lister Lang Walker's stockmarket investments are mainly in speculative biotechs. At the moment only one is doing well.
- Updated
- John Stensholt
January 2015
‘Patient capital’ is best medicine for biotech sector
A group of wealthy backers including billionaire property developer Lang Walker are hoping that Richard Treagus, who is now leading Neuren Pharmaceuticals, is the secret to success in biotechnology investing.
- Jessica Gardner